Longevity Startup Doses First Human in Bid to Reverse Age-Related Sig… | HappeningNow.news
Published Date: June 09, 2026

Technology

Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss

It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.

Source WIRED Updated 1h 58m ago AI Summary

AI Summary

It will be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.

Read full article on WIRED

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence
SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow